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with personality disorders), aiming to invite the reader to 
integrate some aspects of the neurobiology of human sui-
cidal behaviour into a model of suicide that can be used in 
a clinical encounter.
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Introduction
Suicide is receiving increasing attention worldwide, with 
many countries developing national strategies for preven-
tion. Suicide accounts for almost 2 % of deaths worldwide, 
and attempted suicide is more frequent than completed sui-
cide, with a prevalence of 3.5 % (Suominen et al. 2004). 
the definition of suicidal behaviours encompasses a broad 
constellation of heterogeneous entities differing not only in 
manifestation, but also in their background (Courtet et al. 
2004).
Forms of suicidality include suicidal ideations, impul-
sive suicide attempts with low lethality, highly lethal failed 
suicide attempts and completed suicide (Bondy et al. 2000) 
and involve the intention to die and the lethality of method 
(Bondy et al. 2000). the nature of the suicidal act may 
range from impulsive to carefully premeditated and from 
aggressive/punitive or violent to non-violent or passive.
Suicide can either be attempted or completed, although 
an overlap has been noted given that about two-thirds 
of suicide victims have made one or more prior suicide 
attempt(s), and non-violent suicide attempters frequently 
change their suicide method from non-violent to vio-
lent (Rihmer 2007). Attempted suicide is a self-damaging 
act aimed at ending one’s life resulting in failed suicide 
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and suicide gesture. Failed suicide, provoked by a strong 
intent to die, involves careful planning and a highly lethal 
method, whereas suicide gesture (usually provoked by an 
interpersonal conflict) involves less preparation and less 
lethal methods with low intent to die (Mann 1998).
the great diversity of suicidal behaviours reflects their 
association with a range of disorders. these include major 
depressive disorder (MDD), substance-related disorders 
and personality disorders, including borderline personality 
disorder (BPD). Comorbidity among these disorders and 
between these disorders and suicide behaviour is common 
(Bondy et al. 2000; Dumais et al. 2005a, b). Suicide and 
attempted suicide are complex behaviours. A large num-
ber of proximal and distal risk factors have been identified 
(Hawton and van Heeringen 2009) which can be catego-
rized into explanatory models aiming to understand suicidal 
individuals and facilitate suicide risk assessment. the most 
widely accepted risk factors for suicidal behaviour involve 
psychiatric–psychological and socioeconomic factors, 
while the biological, neurochemical and genetic contribu-
tions to suicidality have not yet been as fully elucidated.
On a neurobiological level, dysfunction of the seroton-
ergic system has been shown to be implicated in a number 
of psychiatric afflictions including MDD, BPD and suicide 
(Oquendo and Mann 2000; Bortolato et al. 2013; Di Gio-
vanni et al. 2008). Many studies have provided important 
information regarding the anatomy, development and func-
tional organization of the 5-Ht system and the alterations 
in this system that are present within the brain of the sui-
cidal patient (Pandey 2013). On a psychotherapeutic level, 
early models have identified key determinants operating 
during the development of disorders or behavioural prob-
lems. Several have focused on, among other factors, the 
cognitive and emotional characteristics of depression and 
personality disorders. this conceptual approach and the 
empirical research motivated by such models have led to 
significant insights into these disorders (Ingram and Luxton 
2005; nadort et al. 2009).
Our aim is to review the scientific literature on the con-
tribution of the serotonergic system to suicidal behaviour 
as well as to dysfunctional attitudes and personality traits 
associated with the suicidal patient. Although we will dis-
cuss data from studies investigating both suicide completers 
and attempters interchangeably, we acknowledge that these 
two phenotypes are likely to only partly share underly-
ing aetiological and neurobiological mechanisms (turecki 
et al. 2012). the association of the 5-hydroxyindoleacetic 
acid (5-HIAA), the 5-Ht2A/2C receptors and the serotonin 
transporter promoter region (5-HttLPR) polymorphism 
and suicidal behaviour along with animal models will be 
discussed. Finally, the relationship between neurobiologi-
cal models and psychotherapeutic interventions for sui-
cide prevention will be discussed with a focus on Schema 
therapy (an approach that has shown particular promise in 
the treatment of suicidal individuals with personality disor-
ders), aiming to invite the reader to integrate some aspects 
of neurobiology of human suicidal behaviour into a model 
of suicide that can be used in a clinical encounter.
Serotonergic function in suicide
Cerebral spinal fluid 5-hydroxyindoleacetic acid in suicidal 
behaviour
Given the inaccessibility of the human brain, initial stud-
ies of the biology of suicidal behaviour and development 
of biomarkers focused on peripheral tissues such as cer-
ebrospinal fluid (CSF), urine, platelets and serum. Initial 
evidence for the involvement of 5-Ht in suicide stemmed 
from findings of low CSF 5-hydroxyindoleacetic acid 
(5-HIAA) levels in depressed suicide attempters and in the 
brain stems of completed suicides (Asberg 1997; Asberg 
et al. 1976; Banki et al. 1984; Carlsson et al. 1980; Mann 
and Malone 1997; Placidi et al. 2001; Roy et al. 1986; 
träskman et al. 1981). Although the link between low CSF 
5-HIAA and suicidality has been debated (Roggenbach 
et al. 2002), significantly lower levels of CSF 5-HIAA have 
also been reported in a meta-analysis of CSF metabolite 
studies in subjects who made prior suicide attempts and 
those who subsequently committed suicide (Lester 1995). 
Further investigation on the relationship between CSF 
5-HIAA and prefrontal (PFC) 5-Ht has shown a positive 
correlation between the two in autopsied subjects (Stanley 
et al. 1985). In addition, more recent studies have shown 
that suicide attempters exhibit a blunted release of prolac-
tin in response to administration of fenfluramine, a measure 
of 5-Ht activity (Dulchin et al. 2001; Duval et al. 2001; 
Malone et al. 1996; Mann 1995; Pandey 1997; Weiss and 
Coccaro 1997).
5-Ht receptor in suicidal behaviour
With regard to 5-Ht receptor dysfunction in suicide and 
aggression, the most studied have been the 5-Ht1, 5-Ht2 
subtypes (Bortolato et al. 2013; Panariello et al. 2011). We 
will focus on 5-Ht2 receptors that have been implicated 
in a wide variety of conditions including obesity, anxiety, 
depression, obsessive compulsive disorder, schizophrenia, 
migraine and erectile dysfunction (Di Giovanni et al. 2008, 
2011).
5-Ht2A receptor in suicidal behaviour
In vivo neuroimaging techniques provide a great oppor-
tunity to further elucidate the link between adverse 
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environmental conditions, biomarkers and the symptoms 
or traits implicated in suicidal behaviour. Early evidence 
suggests that increased 5-Ht2A receptor binding in the pre-
frontal cortex, specifically Brodmann area 9, constitutes 
the most consistent post-mortem biological abnormality of 
suicide (Arango et al. 1990, 1992; Mann et al. 1986; Stock-
meier et al. 1997; turecki et al. 1999; Pandey et al. 2002; 
Stockmeier 2003). Although these abnormalities were 
reported as alterations in 5-Ht2 receptor binding, it seems 
as if these studies investigated 5-Ht2A receptors as ligand 
binding to 5-Ht2C receptors (Hoyer et al. 1986). In addi-
tion, the mRnA of 5-Ht2B receptors has low expression 
levels in cortex (Schmuck et al. 1994). Given that these 
findings were reported in studies in which diagnosis of 
the suicide victim was unrestricted together with the con-
sistency noted between those studies with depressed and 
medication-free suicide victims (Hrdina et al. 1993; Yates 
et al. 1990), questions are raised concerning the extent to 
which this finding is associated with a specific diagnosis, 
a symptom cluster associated with suicide or represented 
a biomarker of suicidal ideation. Although the aforemen-
tioned finding was noted in studies of victims who com-
mitted suicide by violent means (Arango et al. 1990; Arora 
and Meltzer 1989; Mann 1996; Hrdina et al. 1993), it was 
unclear how this abnormality could be linked with symp-
tomatology or personality traits. A recent autopsy study 
has proposed that suicide victims dying by violent means 
exhibited greater planning of suicide or a predisposition 
towards aggressive behaviour (Dumais et al. 2005a, b). 
Since it is much easier to recruit subjects with specific 
diagnoses in vivo, most neuroimaging studies of 5-Ht2A 
receptors focused upon three diagnostic areas in relation to 
5-Ht2A receptors: MDD, BPD and antisocial personality 
disorder (APD).
MDD and prefrontal 5-Ht2A binding in suicidal behaviour
neuroimaging studies of 5-Ht2A receptors in depressed 
and healthy samples seem to be inconsistent with the post-
mortem findings as many of these between-group compari-
sons reported a regional decrease in 5-Ht2A binding, which 
could probably be attributed to selective serotonin reuptake 
inhibitor (SSRI) treatment (Dhaenen et al. 1992; Biver et al. 
1997; Attar-Levy et al. 1999; Mintun et al. 2004; van Heer-
ingen et al. 2003; Audenaert et al. 2001). Since these initial 
studies sampled people with recent antidepressant treat-
ment, the initial impression was that regional 5-Ht2A bind-
ing tended to be reduced in MDD. However, further studies 
on depressed subjects not being in antidepressant treatment 
failed to reveal any differences compared to healthy con-
trols (Meyer et al. 1999; Meltzer et al. 1999). Specifically, 
Meyer et al. (1999) sampled medication-free (>6 months) 
subjects with no comorbid psychiatric afflictions, in the 
midst of a major depressive episode (MDE) from early 
onset MDD and by applying [18F]setoperone, a very good 
radioligand for imaging 5-Ht2A receptors, no difference in 
prefrontal cortex 5-Ht2A binding was found as compared 
to healthy controls.
the inconsistency between studies of suicide victims 
and neuroimaging studies of MDEs could be attributed to 
the presence of a subgroup of subjects with MDEs who 
have the biological abnormality reported in suicide victims 
(e.g. low extracellular serotonin). 5-Ht2A receptor density 
has an inverse relationship with extracellular serotonin 
levels, i.e. the density of 5-Ht2A receptors in the cortex 
increases after chronic serotonin depletion and decreases 
after chronically raising extracellular serotonin (O’Regan 
et al. 1987; todd et al. 1995). the symptom used to iden-
tify this subgroup was the elevated pessimism (dysfunc-
tional attitudes) observed during MDEs. there is a modest 
level of dysfunctional attitudes in health, which increases to 
a variable extent during depressive episodes (Simons et al. 
1986; Fava et al. 1994). Greater pessimism during MDEs 
is an important symptom that contributes to the generation 
of sad mood and is targeted by cognitive therapy as well 
as SSRI treatment (Simons et al. 1986; Fava et al. 1994). 
Increasing extracellular serotonin after administration of 
intravenous d-fenfluramine is associated with a strong shift 
in dysfunctional attitudes towards optimism in healthy indi-
viduals (Meyer et al. 2003). this argues that among the 
many roles of serotonin, one of them is to modulate dys-
functional attitudes in humans. Both the anterior cingu-
late cortex and dorsolateral and medial PFC participate in 
functions related to optimism and pessimism (Sharot et al. 
2007; Mitterschiffthaler et al. 2008; Elliott et al. 2002).
A strong correlation has been observed between the 
severity of dysfunctional attitudes (pessimism) and eleva-
tion in cortex 5-Ht2A binding potential, reflecting specific 
binding relative to free and non-specific binding (BPnD). 
Moreover, cortex 5-Ht2A BPnD was significantly elevated 
in subjects with MDE and severe pessimism (Meyer et al. 
2003). there was a strong, significant correlation between 
severity of pessimism and prefrontal cortex 5-Ht2A BPnD. 
In a separate study of a large sample of healthy subjects, 
two personality facets related to pessimism (vulnerability 
and anxiety) were also positively correlated with prefron-
tal cortex, temporal cortex and left insula 5-Ht2A BPnD 
(Frokjaer et al. 2008).
the investigations correlating severity of dysfunctional 
attitudes with greater 5-Ht2A BPnD (Meyer et al. 2003) are 
highly consistent with post-mortem investigations report-
ing greater 5-Ht2A receptor density in the prefrontal cor-
tex of suicide victims. Fifty per cent of suicide victims 
suffer from MDD (Robins et al. 1959). the dysfunctional 
attitudes scale (DAS) is highly correlated with hopeless-
ness measured with the Beck Hopelessness Scale (Cannon 
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et al. 1999; norman et al. 1988). Given that hopelessness 
is a risk factor for suicide (Beck et al. 1985, 1989), it is 
plausible that investigations of suicide victims reporting 
increased 5-Ht2A BPnD sampled depressed subjects with a 
greater severity of pessimism.
Personality disorders (BPD/APD) and prefrontal 5-Ht2A 
binding in suicidal behaviour
BPD and APD constitute two other psychiatric condi-
tions on which the studies of suicide victims have focused 
(Barraclough et al. 1974; Robins et al. 1959; Brodsky et al. 
1997). 5-Ht2A binding in medication-free BPD patients 
showed no difference in the prefrontal cortex (Meyer et al. 
2003); however, an increase in 5-Ht2A binding in the hip-
pocampus was found (Soloff et al. 2007). 5-Ht2A binding 
in aggressive individuals revealed no group difference in 
any region, but an age interaction such that 5-Ht2A binding 
tended to increase considerably more with age in individu-
als with aggression (Meyer et al. 2008). this age-related 
effect might represent an index of differential change in 
pyramidal cell loss, since most 5-Ht2A receptors are found 
in apical dendrites of pyramidal cell neurons and the pat-
tern of loss of pyramidal cells matches the loss in 5-Ht2A 
receptors with age (Jacobs et al. 1997; Jakab and Goldman-
Rakic 1998; Santana et al. 2004). Greater 5-Ht2A receptor 
binding has also been reported recently in the orbitofron-
tal cortex of impulsively aggressive personality disordered 
individuals (Rosell et al. 2010). However, this finding 
should be treated with caution as participants were not 
subjected to urine screening for substance abuse, a condi-
tion commonly comorbid with aggression. Such substances 
may bias 5-Ht2A receptor binding (Bubar and Cunningham 
2008). Consequently, among the investigations of 5-Ht2A 
binding, there is support for increased binding in older indi-
viduals with aggression throughout the cortex and in the 
orbitofrontal cortex in people with aggression.
the evidence of greater 5-Ht2A density in the PFC of 
suicide victims in post-mortem studies should be rein-
terpreted through the prism of diagnostic and symptom-
specific findings from neuroimaging studies of 5-Ht2A 
binding. MDD with high levels of pessimism is associated 
with greater prefrontal cortex 5-Ht2A binding. Half of the 
suicide victims have MDD and hopelessness (highly corre-
lated with pessimism), which is associated with heightened 
risk of suicide (Beck et al. 1985, 1989; Cannon et al. 1999). 
the diagnosis of BPD does not contribute to the find-
ing of greater prefrontal cortex 5-Ht2A density in suicide 
victims since no change in prefrontal 5-Ht2A BPnD was 
found (Meyer et al. 2003; Soloff et al. 2007). In those with 
aggressive behaviour, a subgroup of subjects older than 
age 34 show a similar neurobiological finding and would 
be expected to also contribute to the original findings of 
greater prefrontal 5-Ht2A density in suicide victims (Meyer 
et al. 2008; Rosell et al. 2010).
5-Ht2A receptors in aggression and suicide
Impulsive and aggressive traits are postulated to be part 
of the diathesis for suicidal behaviour (Mann et al. 1999). 
High levels of aggressive behaviour have been associated 
with suicidal behaviour, especially lethal suicide attempts. 
Impulsive behaviour has been shown to be highly related 
to non-fatal suicide attempts (Oquendo et al. 2004). As 
mentioned earlier, low levels of 5-Ht have been implicated 
in impulsive violence and aggression in studies including 
low CSF 5-HIAA in individuals with a lifetime history of 
aggressive behaviour with personality and other psychi-
atric disorders (Brown and Goodwin 1986; Stanley et al. 
2000). Low levels of 5-Ht have also been associated with 
a blunted prolactin response to serotonin-releasing agent 
fenfluramine in personality disorder patients (Coccaro 
et al. 1989, 1995). Increased levels of 5-Ht2A receptor 
binding correlated with aggressive behaviour in personal-
ity and other psychiatric disorder patients (McBride et al. 
1994; Coccaro et al. 1989). A role for serotonergic function 
in aggressive and to a lesser extent, impulsive behaviour, 
is well documented (Ryding et al. 2006; Congdon et al. 
2008), consistent with observations that low SERt bind-
ing associated with suicide appears to be concentrated in 
the ventromedial PFC and anterior cingulate regions, which 
play a role in mediating inhibition and restraint (Arango 
et al. 1995; Mann et al. 2000). However, using post-mortem 
brain tissue, platelets, and DnA from suicide completers 
and attempters has not provided unequivocal evidence for 
a pre-eminent role for the SERt in the pathophysiology of 
suicide (Purselle and nemeroff 2003).
5-Ht2C receptors in aggression and suicide
Despite the intense research on 5-Ht2C receptors show-
ing its pivotal involvement in different neuropsychiatric 
disorders, only recently has the first selective agonist lor-
caserin (Beliviq, Arena Pharmaceutical) advanced into 
the clinic, it was approved in 2013 by FDA for the treat-
ment of obesity (Berlie and Hurren 2013). this paradoxi-
cal situation is due to the lack of selective pharmacological 
tools capable of overcoming the high degree of homology 
among 5-Ht2 receptors and, above all, the complexity 
of 5-Ht2C signalling. Indeed, the 5-Ht2C receptor is the 
only known G protein-coupled receptor (GPCR) subject 
to a form of post-transcriptional modification known as 
RnA editing (Di Giovanni et al. 2006). this is a process 
in which specific adenosine residues are converted to ino-
sine resulting in functional recoding of the mRnA that can 
generate up to 24 different protein isoforms with distinct 
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functional properties. Post-mortem, animal and pharmaco-
logical studies have suggested that 5-Ht2C receptor and 
their altered RnA editing is involved in the pathophysiol-
ogy of mental disorders including aggression and suicide, 
although results remain inconsistent (Panariello et al. 2011; 
Bortolato et al. 2013; Di Giovanni et al. 2006, 2011). For 
instance, an increased density of prefrontal cortex 5-Ht2CR 
mRnA (Pandey et al. 2006) and differences in pre-mRnA 
editing of these receptors between control subjects and 
suicidal victims have been found (Gurevich et al. 2002; 
Dracheva et al. 2008). Consistently, full edited 5-Ht2CR 
receptor mice displayed enhanced anxiety-like behaviour 
in response to the preferential 5-Ht2C agonist, m-chloro-
phenylpiperazine (mCPP; Di Giovanni et al. 2000), in the 
social interaction test and increase in freezing behaviours in 
reaction to an innately aversive ultrasonic stimulus (Martin 
et al. 2013). these authors suggested that enhanced 5-Ht2C 
receptor editing through interference from alternative splic-
ing would lead to a deficit of truncated receptors that nor-
mally exert a dominant negative effect on the addressing of 
the full-length 5-Ht2C receptor protein to the membrane 
(Martin et al. 2013). Moreover, it is known that the pharma-
cological stimulation of 5-Ht2C receptors reduces aggres-
sive responses and enhances the display of submissive 
behaviour (Rosenzweig-Lipson et al. 2007; Dekeyne et al. 
2012; Harvey et al. 2012). these effects, however, may 
result from a general enhancement in social anxiety caused 
by drugs acting at 5-Ht2C receptors capable of induc-
ing panic attack in humans (Charney et al. 1987). Indeed, 
increased neuroendocrine and anxiety responses to mCPP 
were observed in some individuals with MDD (Ghaziuddin  
et al. 2000). In addition, an increased in response to mCPP 
in cerebral blood flow of left frontal of individuals carry-
ing the 5-Ht2C-Cys-23-Ser polymorphism in the 5-Ht2C 
coding region was observed (Kuhn et al. 2004). In con-
trast, most studies failed to identify significant associa-
tions among polymorphisms of this receptor and suicidal 
attempts (Zhang et al. 2008; turecki et al. 2003; Serretti 
et al. 2007, 2009; Arias et al. 2001), completed suicide 
(Stefulj et al. 2004), the severity of suicidal behaviours (De 
Luca et al. 2008; Di Giovanni et al. 2011; Panariello et al. 
2011) or suicide risk and deliberate self-harm (Pooley et al. 
2003). On the other hand, the latest available study detected 
a significant association between completed suicide and the 
variants of 5-Ht2C-Cys-23-Ser polymorphism but not the 
mutation G-995A (promoter region) in the 5-Ht2C of Slo-
venian suicide victims (Videtic et al. 2009).
Since 5-Ht2C receptors are preferentially expressed on 
GABAergic interneurons (Serrats et al. 2005; Boothman 
et al. 2006; Liu et al. 2007; Di Giovanni et al. 2001), their 
hyperactivity and/or increase density/editing lead to an 
increase in the GABAergic function in areas such as the 
frontal cortex, other limbic structures and the raphé nuclei 
determining a decrease in 5-Ht turnover seen in aggres-
sion and suicide (Bortolato et al. 2013; Oquendo and Mann 
2000).
Serotonin transporter imaging and post-mortem studies  
of suicide victims
In addition to the post-mortem studies of serotonin trans-
porter (5-Htt) binding in depression (with or without 
concurrent suicide), decreased 5-Htt binding has been 
reported in the ventral prefrontal cortex associated with sui-
cide, independent of diagnosis (Mann et al. 2000; Arango 
et al. 1995). Comparison between suicide victims with a 
history of depression and suicide victims without a history 
of depression yielded significantly lower 5-Htt binding in 
ventral prefrontal cortex in the suicide victims (Mann et al. 
2000). Additionally, both groups of suicide victims had 
lower ventral prefrontal cortex 5-Htt binding as compared 
to non-suicide controls.
Further neuroimaging investigations have identified the 
conditions associated with decreased global 5-Htt bind-
ing describing a region-specific pattern that matches a pre-
dominant lower level of ventral prefrontal cortex binding 
(Meyer et al. 2001, 2004). Global reductions in 5-Htt 
binding may be observed following antidepressant treat-
ment (Meyer et al. 2001, 2004; Suhara et al. 2003), in fall/
winter season relative to spring/summer (Praschak-Rieder 
et al. 2005), as well as following ecstasy abuse, where 
a reduction in 5-Htt binding seems to be selectively 
affecting cortical regions including the striatum and mid-
brain (McCann et al. 2005; Selvaraj et al. 2009). A similar 
region-specific effect has been recently reported in studies 
with patients suffering from obsessive–compulsive disor-
der (OCD) where the lowest 5-Htt binding was noted in 
ventral prefrontal cortex (Matsumoto et al. 2010; Reimold 
et al. 2007). Given that substance abuse and anxiety disor-
ders are correlated with higher risk for suicide, it could be 
argued that ecstasy abuse and OCD could contribute to the 
diminished ventral prefrontal cortex 5-Htt binding in sui-
cide completers (Mann et al. 2000).
Further experimentation supports the hypothesis that 
5-Htt binding in impulsivity, as well as other maladap-
tive behaviours related to risk for suicide, is associated 
with 5-Htt binding reduction. Studies on early maternal 
separation in peer-reared rhesus monkeys (an animal model 
which will be discussed in another section of this review), 
who later exhibited aggressive and impulsive behaviour, 
have reported loss of 5-Htt binding restricted in areas 
including the midbrain, thalamus, caudate, putamen and 
anterior cingulate cortex, but not the prefrontal cortex 
(Ichise et al. 2006). neuroticism, a personality trait which 
may involve impulsivity, has been positively correlated 
with thalamic 5-Htt binding (takano et al. 2007) and 
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negatively associated with openness to values, the latter of 
which has shown a negative correlation with 5-Htt bind-
ing in subcortical regions (Kalbitzer et al. 2009). Aggres-
sion has also been linked with low levels of 5-Htt bind-
ing in the anterior cingulate cortex (Frankle et al. 2005) but 
with greater 5-Htt binding in brain stem of people with 
BPD (Koch et al. 2007). the degree to which these bind-
ing changes take place in the prefrontal cortex cannot be 
assessed due to the radiotracing methods utilized in these 
studies. neuroimaging studies of 5-Htt binding in impul-
sivity and related conditions have not provided evidence 
confirming the ventral prefrontal cortex pattern of 5-Htt 
binding loss reported by post-mortem studies targeting this 
specific region (Mann et al. 2000; Arango et al. 1995).
Serotonin transporter in personality traits linked  
with suicide
Genetic studies focusing on 5-Ht-related genes in search of 
genetic markers of suicide suggest that the 5-Ht transporter 
length polymorphic region (5-HttLPR) polymorphism 
of the serotonin transporter gene is strongly related to sui-
cide (Costanza et al. 2013; Gonda et al. 2011). the short 
(s) allele of the 5-HttLPR is associated with reduced sero-
tonin transporter (5-Htt) protein availability and function 
(Canli and Lesch, 2007) compared with the long (L) form. 
the presence of at least one s allele has been proposed 
as a predictor of suicidal behaviour (Bondy et al. 2006). 
Considering the different suicidal phenotypes, including 
a review of related meta-analyses, the s allele seems to be 
associated with impulsive and aggressive suicidal behav-
iours and completed suicide (Bondy et al. 2000) and vio-
lent (Bayle et al. 2003; Bellivier et al. 2000; Courtet et al. 
2001) as well as repeated suicide attempts (Courtet et al. 
2004). A recent meta-analysis suggests that 5HttLPR and 
the RS1800532 (tryptophan hydroxylase variant) polymor-
phisms are significantly associated with suicide attempts, 
but not associated with completed suicides (Clayden et al. 
2012).
the presence of the s allele of the 5HttLPR has been 
associated with the development of BPD (ni et al. 2006). 
A recent study has shown that among a broad range of 
psychiatric disorders, patients with BPD are at particu-
larly high risk for suicide completion (Qin 2011) making 
up 9–33 % of the total number (Pompili et al. 2005). two 
meta-analyses (Samual and Widiger 2008; Saulsman and 
Page 2004) have found consistent high positive correla-
tions between various measures of BPD and neuroticism as 
defined and measure by the nEO PI-r (Costa and McCrae 
1995). In fact, BPD has the strongest and most consistent 
correlation with neuroticism among the personality dis-
orders with BPD having significant correlations with all 
six of its facets. thus, neuroticism can be seen as a core 
trait underlying BPD (Samual and Widiger 2008; Sauls-
man and Page 2004). neuroticism is among the traits that 
consistently have been associated with suicide ideation, 
attempts and complete suicide (Brezo et al. 2006). Lesch 
et al. (1996) found a significant correlation between the s 
allele and neuroticism. this investigation inspired many 
subsequent attempts at replication. the results have been 
inconsistent with studies supporting (Gonda et al. 2009) 
and not supporting (Willis-Owen et al. 2005) this find-
ing. the majority of these studies were underpowered, 
with sample sizes being small relative to what is needed 
to draw conclusions based on the small effect size that 
can be attributed to a single gene. two studies that were 
adequately powered (Willis-Owen et al. 2005; terracciano 
et al. 2009) did not find a correlation, however, several 
meta-analyses did (Schinka et al. 2004; Sen et al. 2004; 
Munafo et al. 2005). the latter two investigations clarified 
that finding a correlation was dependent upon the method 
of meta-analysis being used. Genetic variations other than 
those associated with 5-HttLPR have been explored but to 
date, after a decade of effort, no others have been found to 
correlate with neuroticism, underscoring the importance of 
the link between the two (Canli 2008). Primates who carry 
the homologue of the s allele express phenotypic features 
of neuroticism (e.g. increased anxiety and reduced social 
interaction; Hariri 2006).
Another line of investigation has looked at the possi-
bility that the s allele is not itself correlated with negative 
affect but interacts with adversity, leading to neuroticism 
or such states as depression or anxiety in the face of nega-
tive life events. these studies were also initially leading 
to inconsistent findings. A recent large-scale, highly pow-
ered study (Middeldorp et al. 2010) and two meta-analyses 
(Munafo et al. 2009; Risch et al. 2009) concluded that the 
s allele did not moderate the interaction between negative 
life events and neuroticism. However, Uher and McGuffin 
(2009) have shown that the method of assessment of envi-
ronmental adversity led to these negative results. When 
self-report measures were used, no moderating effect was 
found, but when detailed interview-based measures were 
used, the s allele was indeed found to have a moderating 
effect. this moderating effect has been clearly demon-
strated in non-human primates (rhesus macaques). Infant 
primates who were deprived of adequate maternal care 
(i.e. peer raised) and who carried the s allele manifested 
heightened anxiety and depression, reduced engagement 
in play, greater aggression and increased alcohol consump-
tion relative to L allele carriers (Champoux et al. 2002; 
Meaney 2001; nelson et al. 2009). Mother rearing elimi-
nated the differences between the two groups. Studies that 
have demonstrated this interaction in humans have found 
that children who carried the s allele who were exposed to 
emotional and or physical abuse showed increased levels 
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of anxiety, depression and cortisol secretion (Caspi et al. 
2003; Stein et al. 2008; taylor et al. 2006). Human infants 
who carry the s allele and who experience poor childrear-
ing conditions are more likely to develop a negative emo-
tional temperament (Auerbach et al. 2001). Individuals 
diagnosed with BPD or APD almost always suffer from 
severe childhood adversity. the interaction between these 
adverse experiences and the s allele is demonstrated by the 
finding that the relative risk of developing BPD or APD has 
been shown to increase by a factor of 2 for each short allele 
the individual carries (Gunderson and Lyons-Ruth 2008).
It is important to note that the impact of the s allele goes 
beyond an influence on anxiety and depression. It has been 
associated with bipolar and unipolar affective disorder, 
OCD, eating disorders, attention-deficit/hyperactivity dis-
order, neurodegenerative disorders and of particular impor-
tance in relation to the current discussion, suicide (Murphy 
and Lesch 2008). the s allele has been found to be asso-
ciated with general impulsivity in the context of a broad 
range of emotionally evocative situations when the individ-
ual has been exposed to adverse environments in childhood. 
the combination of greater impulsivity and heightened lev-
els of emotional pain associated with the s allele × child-
hood adversity interaction strengthens the link with suici-
dality. this combination is reflected in the significant and 
consistent negative correlation found between the Consci-
entiousness scale of the nEO PI-r and BPD and the strong 
positive correlations between neuroticism and BPD (Sam-
ual and Widiger 2008; Saulsman and Page 2004). negative 
scores on the Conscientious scale reflect difficulties with 
restraint and impulse control.
the vast majority of this research has been conducted 
within the diathesis-stress framework and, as a result, has 
not examined these interactions from the vantage point of 
what is called the differential susceptibility or “plasticity 
hypothesis” (Belsky and Pluess 2009). the diathesis-stress 
model focuses solely on the negative impact stress can have 
when impinging on an area of vulnerability. the plasticity 
hypothesis suggests that some individual differences can 
lead to bad outcomes in the face of adversity or very good 
outcomes in the context of enriched environments. Meta-
phorically what was viewed as a source of fragility and 
as operating like glass in the face of a stone is now seen 
as something more like clay that can form a deep impres-
sion for the better or worse. Looking at the impact of both 
positive and negative life events on the link between the s 
allele and neuroticism would allow for an examination of 
the full scope of its potentially moderating effect. On the 
positive side, carriers of two short alleles have been found 
to have more pulvinar neurons (Young et al. 2007). Pulvi-
nar neurons are involved in the processing of visual signals 
sent to the limbic system via a subcortical route. More neu-
rons mean a stronger connection and may be associated 
with a greater capacity to detect the emotional context of 
an environment. Short allele carriers express greater sym-
pathetic reactivity when observing another person receiv-
ing a shock (Cris¸an et al. 2009), suggesting a possible link 
to a greater capacity for empathy. In another study, it was 
found that seeing a favourite person led to significantly 
higher amygdala activity in short allele carriers suggesting 
a higher reward value of positive interpersonal experience 
(Matsunagaa et al. 2010). Homberg and Lesch (2011) have 
reviewed the many cognitive and emotional advantages that 
correspond to the greater sensitivity and emotional respon-
siveness that has been correlated with the s allele. they 
hypothesize that these advantages may counterbalance 
or completely offset the disadvantages and may also be a 
contributor to some of the inconsistent findings referred to 
above.
Working from the same premise, Pluess et al. (2010) 
studied the interaction between negative and positive life 
events in relation to neuroticism in individuals homozy-
gous for s alleles and L alleles. Consistent with the plas-
ticity hypothesis, they found that those with s alleles who 
experienced more negative life events had higher neu-
roticism scores and those experiencing more positive life 
events had lower neuroticism scores. those with L alleles 
had consistent scores on neuroticism regardless of the num-
ber of positive or negative life events. thus, neuroticism 
may be a more stable trait for those with the L allele and 
less so for those with an s allele. It also may be that those 
with s alleles are more likely to be negatively impacted by a 
toxic childhood, develop maladaptive schemas and exhibit 
a behavioural and affectional pattern that will be associ-
ated with higher neuroticism scores. As noted above, we 
know that s allele carriers are more likely to develop BPD 
when exposed to toxic environments. this greater degree 
of responsiveness to the environment is reflected in the 
finding that human and primate s allele carriers have been 
found to be more responsive at rest in many cortical sites 
(Canli 2008).
Another study supporting the plasticity hypothesis 
was conducted by Antypa and van der Does (2010). they 
asked 250 university students about experiences of emo-
tional abuse in childhood. Emotional abuse is a frequently 
reported occurrence among patients suffering from BPD. 
Cognitive reactivity to sad mood was assessed using the 
Leiden Index of Depression Sensitivity Scale. this meas-
ures habitual negative cognitive patterns and yields scores 
that remain high even when symptoms are low and thus 
overlaps significantly with the notion of an early mala-
daptive schema described in the last section of this review 
(4. Bridging neurobiological models with clinical psycho-
therapy). the results confirmed the plasticity hypothesis. 
Short allele carriers whose scores were very low on a meas-
ure of childhood emotional abuse had extremely low scores 
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on the measure of cognitive vulnerability to depression 
and extremely high scores when they reported high scores 
on measures of abuse. Long allele carriers had moderate 
scores no matter what level of abuse they reported. Put 
another way, the short allele carriers were able to benefit far 
more from a good childhood than the long allele carriers. 
It is important to note that while these recent findings are 
intriguing, replication with a well-powered study is needed 
to confirm or refute these observations. It is estimated that a 
sample size over 1,000 will be needed to have 80 % power 
at a significance level of p = 0.50 (Munafo et al. 2009).
On a neural level, a meta-analysis found a consistent 
correlation between the s allele and greater amygdala reac-
tivity to many forms of negative stimuli relative to neutral 
cues. this included faces expressing fear and anger, and 
negative scenes and words (Canli and Lesch 2007; Hariri 
2006). the strength of this correlation was about six times 
greater than that found on self-report measures. thus, it 
appears that when variables closer to the genetic level 
(endophenotypes) are studied, the links are stronger than 
those found on the phenotypic level (e.g. those assessed 
by the nEO PR-r). Human s allele carriers have also been 
found to have increased anterior cingulate activity, espe-
cially in response to social threat (Jahn et al. 2010; Way 
and taylor 2010). this reactivity was associated with 
greatly increased cortisol secretion.
the L allele and the associated efficient serotonergic 
functioning may lead to greater self-reliance with more 
affective regulation occurring within one’s own synapses. 
the s-allele, associated with less efficient serotonergic 
functioning, may lead to an adaptive strategy that draws 
more on deep and enriched ongoing attachments to regulate 
affect. We could view this as emphasizing regulation across 
a “social synapse”. this is a genetic variation that goes 
deep into our past as a species and, interestingly, humans 
and rhesus macaques are the only two species which have 
it. Humans and rhesus macaques are known as the “weed” 
species since both proliferate wherever they are placed in 
the world. It seems that both adaptive strategies (self-reli-
ance and strong attachments) are important to the collective 
whole in both of these species and that the latter flourishes 
in supportive and nurturing interpersonal environments and 
leads to considerable emotional suffering including despair 
and suicidal behaviour in toxic interpersonal contexts.
Animal models of suicide
Animal models are formidable tools to investigate the 
aetiology of an illness, its course, potential treatment 
(Collado and Serrano 2010; Lanzas et al. 2010) and the neu-
robiology of associated behaviour (McKinney 2001). no 
convincing animal models of suicide have been developed 
to date, although many researchers have tried to identify 
suicide in non-human species in the natural setting (Preti 
2007). A range of suicidal behaviour in animals has been 
claimed. For example, animals in captivity or separated 
from their master have been reported to starve to death 
voluntarily (Preti and Miotto 2005; Ramsden and Wilson 
2010) or exhibit self-destructive behaviours (Crawley et al. 
1985); uncontrolled anxiety provoking situations including 
isolation, separation and confinement have been reported to 
result in self-endangering behaviours in primates (Kraemer  
and Clarke 1990; tiefenbacher et al. 2005); monkeys in 
reared isolation showed higher risk of self-endangered 
behaviour in adulthood (Crawley et al. 1985). this latter 
finding parallels the impact of childhood abuse or neglect 
on the risk of suicide in humans (Evans et al. 2005; Brodsky 
and Stanley 2008). However, the degree to which such self-
endangering behaviours in animals resemble self-harming 
behaviour in humans is debatable.
While modelling suicidal behaviour in animals fails to 
reproduce the role of will and intention in suicide mechan-
ics, current animal models are making an effort to forge a 
tighter link by studying each step along the chain of behav-
iours leading to suicide in humans (for review on animal 
models of suicide, see Preti 2011). Among the several dis-
tinct animal models of suicide, learned hopelessness and 
maternal deprivation seem to be particularly promising.
As discussed earlier, hopelessness and pessimism are 
major cognitive factors for suicide, and hopelessness per 
se has emerged as a predictor of suicide attempt and com-
pletion in clinical samples (Beck et al. 1985). the learned 
helplessness paradigm (Seligman 1972) is considered as 
an analog of human hopelessness (Krishnan and nestler. 
2008). these studies have involved series of inescapable 
electrified foot shocks as aversive stimuli, after which a 
subgroup of animals stops any attempt to escape. Follow-
ing retesting after some delay, some animals try to escape 
again, while others indefinitely exhibit despairlike behav-
iour, failing to escape. Although this model offers good 
face validity, as many symptoms in humans (weight loss, 
sleep disturbances, distorted perception of pleasure, etc.) 
can be modelled in animals once learned helplessness has 
established, its ecological validity (i.e. correspondence with 
a real situation in humans) is poor as the model utilizes 
painful stimuli to produce helplessness. Interestingly, all 
antidepressants are effective in reversing the helplessness 
within 3–5 days of administration, compared to a 2–3 week 
delay in humans.
turning to the maternal deprivation model, it has been 
found that early adverse life events (i.e. childhood abuse 
or neglect) and disrupted parenting are associated with an 
increased risk for psychopathology and suicidal behaviour 
in adolescence and adulthood (Agerbo et al. 2002; Lu et al. 
2008; Afifi et al. 2009). Maternal deprivation (Lovic et al. 
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2001; Gonzalez et al. 2001) in rodents has been used as a 
model of human disrupted parenting. Studies have shown 
that maternal separation leads to an increase in the typical 
markers of stress (Walker et al. 1991) and to reduced activ-
ity of the main inhibitory neurotransmitters in the brain 
(newport et al. 2002). Moreover, female offspring separated 
from their mothers showed aberrant maternal care in adult-
hood (Lovic et al. 2001; Gonzalez et al. 2001). Maternally 
deprived monkeys exhibited depressive-like symptoms dur-
ing development, including low CSF noradrenaline concen-
trations (Kraemer et al. 1991), increased self-administration 
of alcohol (Fahlke et al. 2002) and self-endangering behav-
iour (Kraemer and Clarke 1990; tiefenbacher et al. 2005). 
All of these findings lend support to the face and predictive 
validity of this model regarding the main correlates of major 
depression [i.e. comorbidity with alcohol abuse (Grant and 
Harford 1995) and increased risk of self-harming behaviour 
(Angst et al. 2005; tondo et al. 2008)].
Given the difficulties in animal modelling, an intermedi-
ate phenotype in the animal must be specifically tested for 
validity and reliability (Geyer and Markou 1995; Boulou-
gouris et al. 2009). Isolating and studying relevant endo-
phenotypes will also be important. this will involve a focus 
on intermediate and behavioural markers proximal to genes 
(Gottesman and Gould 2003). A number of investigators 
have begun this process focusing on rhesus macaques. this 
population is of particular importance in animal modelling 
since they share over 98 % of their genetic material with 
humans, and as mentioned above, rhesus macaques are 
linked with humans in terms of a number of key genetic 
polymorphisms. Since rhesus macaques’ early develop-
ment involves a strong, exclusive, unique and enduring 
bond between mother and infant that has a high degree of 
overlap with Bowlby’s (1969) characterization of human 
mother–infant attachment, this work has direct relevance to 
the maternal deprivation model.
Peer-only (PO) rearing (maternally deprived) has been 
found to lead to monkeys that, at a phenotypic level, are 
highly anxious, aggressive and impulsive and on a neu-
roendocrine (HPA) level exhibit more extreme responses 
to social separation (Suomi 1997; Dettmer et al. 2012). 
they have lower levels of CSF 5-HIAA concentrations 
than mother-reared monkeys from early infancy to later 
adulthood (Shannon et al. 2005; Higley and Suomi 2011) 
and have significantly different peripheral measures of 
neurotrophic factors nGF and BDnF (Cirulli et al. 2009) 
and as adolescents and young adults consume significantly 
more alcohol than their mother-reared counterparts during 
a “happy hour” situation (Higley et al. 1991; Fahlke et al. 
2002). neuroimaging studies have also shown the PO-
reared monkeys to differ significantly in brain function and 
structure (Doudet et al. 1995; Ichise et al. 2006; Spinelli 
et al. 2009). Finally, major differences have been found in 
genome-wide expression in leucocytes between PO-reared 
and mother-reared monkeys (Cole et al. 2012). Depriva-
tion of adequate maternal care clearly has profound nega-
tive consequences for rhesus monkeys at phenotypic levels 
as well as neuroendocrine output, neurotransmitter metab-
olism, brain structure and function and even genome-wide 
expression. these consequences are linked to risk factors 
associated with suicide (e.g. high emotional reactivity, 
aggression, impulsivity and increased alcohol consumption).
Studies of this population examining the interaction 
between maternal deprivation and genetic polymorphisms 
have led to several dramatic discoveries that contribute to 
animal models of suicidal behaviour and have a bearing on 
prevention and treatment. these discoveries, in line with 
the plasticity hypothesis described above, have demon-
strated that when monkeys born with so-called risk alleles 
[such as the short allele of the 5-Htt or the less function-
ally efficient MAOA allele, in addition to polymorphisms 
in the corticotrophin releasing factor (CRH) 2A gene, 
the neuropeptide Y (nPY) gene and the mu opioid recep-
tor gene] are deprived of adequate maternal care, they 
develop the range of negative consequences outlined above 
but when monkeys with these less efficient variants have 
normal mothering not only do they develop normally but 
in some ways (e.g. consuming less alcohol during happy 
hours) function better than their L allele counterparts. 
thus, these alleles seem to be a risk factor in depriving 
or harsh environments and a protective factor in benevo-
lent environments (Suomi 2011). the potential benefits of 
these less efficient variants are most likely underappreci-
ated at present due to the fact that these studies, except for 
one that will be discussed later, have not been assessing the 
impact exceptionally good mothering over and above nor-
mal mothering has on these polymorphisms. the plasticity 
hypothesis would predict that these alleles have evolved in 
a way that capitalizes on this difference.
While endophenotypes, such as those discussed above, 
have been proposed as physiological and behavioural 
markers and important gene × environment interactions 
identified that relate to susceptibility to a psychiatric dis-
order (Hitzemann 2000; nestler and Hyman 2010), endo-
phenotypes for each link in the suicidal behaviour chain 
have yet to be identified. Clarification of clinical and psy-
chotherapeutic models of suicidal behaviour is a prereq-
uisite for the implementation of valid and reliable animal 
models.
Bridging neurobiological models with clinical 
psychotherapy
Different aspects of suicidality that have been associated 
with serotonergic modulation have been the target of several 
Author's personal copy
 Exp Brain Res
1 3
psychotherapeutic approaches. Hopelessness can be con-
ceptualized as a relatively stable schema incorporating neg-
ative expectations concerning the future. Several techniques 
have been developed as a part of cognitive behavioural 
therapy (CBt) in order to challenge and modify negative 
core beliefs. Problem-solving techniques constitute part 
of CBt as well. Both cognitive therapy (Rush et al. 1982) 
and problem-solving training (Salkovskis et al. 1990) have 
been found to reduce hopelessness. Dialectical behavioural 
therapy (DBt) is a form of CBt developed by Linehan for 
the treatment of patients with BPD and suicidal behaviour. 
According to Linehan et al. (1993), BPD is primarily a dys-
function of the emotion regulation system which results 
from biological irregularities combined with certain dys-
functional environments, as well as from their interaction 
and transaction over time. Patients with BPD experience 
enduring aversive states with impulsive, suicidal behaviours 
appearing to be behavioural solutions to intolerably painful 
emotions (Linehan et al. 1993). the effectiveness of DBt in 
reducing suicidal behaviour has been demonstrated by Line-
han et al. (1991) who found that a group of BPD patients 
who received DBt (1) had fewer incidences of parasuicide 
and less medically severe parasuicides, (2) were more likely 
to stay in individual therapy and (3) had fewer inpatient 
psychiatric days, in comparison with a treatment as usual 
group. At the initial 6-month follow-up, DBt subjects had 
significantly less parasuicidal behaviour, less anger and 
better self-reported social adjustment. At the final 6-month 
follow-up, DBt subjects were found to have significantly 
fewer psychiatric inpatient days and better interviewer-rated 
social adjustment (Linehan et al. 1993).
Schema therapy (St) is an integrative psychotherapy 
that combines elements of cognitive-behavioural, attach-
ment, object relations, psychodynamic and emotion-
focused models. St was developed by Jeffrey Young for 
the treatment of people with chronic characterological 
problems and has been found to be an effective treatment 
for patients with BPD (Farrell et al. 2009; Giesen-Bloo 
et al. 2006; nadort et al. 2009).
the construct of an early maladaptive schema (EMS) 
is central to St. An EMS is defined as a broad, pervasive 
life theme or pattern comprised of memories, emotions and 
cognitions regarding oneself and one’s relationship with 
others developed during childhood or adolescence and 
elaborated throughout one’s lifetime and dysfunctional to 
a significant degree. Suicidal risk and behaviour could be 
conceptualized around the EMS and schema modes. Of the 
full range of 18 EMS which have been defined (table 1), 
the ones (based on clinical observations) that are consist-
ently associated with the most intense painful affect and 
greatest risk of suicidal behaviour are those involving dis-
connection and rejection (e.g. the emotional deprivation, 
social exclusion, mistrust/abuse, and abandonment sche-
mas), especially when they have been developed early in 
childhood. this is clearly linked to the maternal deprivation 
animal model of suicide described in the previous section.
Suicidal behaviour, as distinct from risk, could concep-
tualize in terms of schema modes. there are four distinct 
types: child modes, maladaptive coping modes, maladap-
tive parent modes and a healthy adult mode (table 2). the 
child modes (Vulnerable, Angry, Impulsive/Undisciplined, 
Contented) are ones that humans come into the world 
Table 1  Domains and early 
maladaptive schemas (EMS) 
of schema therapy [taken and 
adapted from Lockwood and 
Perris (2012)]
Disconnection and rejection
typically arises from parenting that is detached, cold,  







Impaired autonomy and performance
typically arises from parenting that is under  
or overprotective, enmeshed and does not help  
to build competent functioning outside of the family







typically arises from parenting that is based on conditional  
approval, is controlling, emphasizes status and appearance,  
or emphasizes rigid rules and expectations about  




typically arises from parenting that is permissive,  
overindulgent, fails to provide structure and direction  
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with and have close parallels to the child emotional sys-
tems that have been identified in mammalian brains (fear, 
panic, rage, seeking and play; Panskeep 1998). the Vulner-
able Child mode, in the case of individuals who have suf-
fered parental neglect and/or abuse, is characterized by an 
ongoing sense of deprivation and/or abuse and is labelled 
the Deprived/Abandoned or Abused Child mode. the 
Deprived/Abandoned/Abused Child mode is the one most 
commonly driving suicidal behaviour. Each mode is seen as 
having characteristic signs and symptoms, its own function 
and as requiring its own strategies to be effectively treated. 
the Deprived/Abandoned/Abused Child mode is charac-
terized by neediness, frantic efforts to avoid abandonment, 
clinging, an idealized view of nurturers and feelings of 
depression, loneliness, hopelessness, despair, fear, panic, 
worthlessness and victimization. the individual feels help-
less to get their needs met or find protection. One of the 
main strategies when this mode is activated and suicidal 
risk is high is to connect to, sooth, reassure and protect the 
“Vulnerable Child” part of the patient and provide enough 
ongoing contact (with the therapist or significant others) 
for the crisis to be weathered and core needs for connec-
tion to be met. this mode and these strategies have close 
parallels to the aforementioned animal models involving 
the central role of maternal deprivation in suicidal risk. 
two other modes, the Detached Protector (one of the mala-
daptive coping modes) and the Punitive Parent (one of the 
maladaptive parent modes) are also involved with suicidal 
Table 2  Description of the schema modes of schema therapy [taken and adapted from Young et al. (2003)]
Child modes
Involve feeling, thinking and acting in a “childlike” manner
Vulnerable child (including abandoned, abused, humiliated, or lonely types) Feels overwhelmed by painful feelings, e.g. anxiety, depression, 
grief, shame/humiliation, or loneliness
Angry child Feels and expresses uncontrolled anger or rage in response to perceived or real mistreatment, abandonment, humiliation, or frustra-
tion; often feels treated unjustly. Acts like a child throwing a temper tantrum
Impulsive, undisciplined child “Wants what he wants when he wants it”. Cannot tolerate the frustration of limits
Maladaptive parent modes
Involve internalized dysfunctional parent “voices”
Punitive/critical parent Internalized, critical or punishing parent voice; harsh criticism directed towards the self; feelings such as shame, guilt or 
self-loathing
Demanding parent Unrealistically high expectations; Pushy, controlling, demanding
Maladaptive coping modes
Involve maladaptive attempts to protect self from pain
Avoidance modes
 Detached protector Emotional detachment used as protection from painful feelings; unaware of feelings; feels “nothing”; appears emotionally 
distant, flat, or robotic; avoids getting close to other people
 Detached self-soother/self-stimulator Uses repetitive, “addictive”, compulsive or self-stimulating behaviours to calm and soothe himself; uses 
pleasurable or exciting sensations to distance himself from painful feelings
 Angry protector A “wall of anger” used to keep others at a safe distance; anger is more controlled than in Angry Child mode
Surrender mode
 Compliant surrenderer Gives into real or perceived demands/expectations of others seen as more powerful in an anxious attempt to avoid pain/
get needs met
Over-compensator modes
 Self-aggrandizer Feels superior, special or powerful; looks down on others; sees the world in terms of “top dog” and “bottom dog”; shows off 
or acts in a self-important, self-aggrandizing manner; concerned about appearances rather than feelings or real contact with others
 Bully/attacker Uses threats, intimidation, aggression, coercion, retaliation to get what he wants; asserts his dominant position; feels sadistic 
pleasure in attacking others
 Con man/manipulator Cons, lies or manipulates to achieve goals; victimizes others; seeks to escape punishment
 Predator Focuses on eliminating threats, rivals, obstacles or enemies in a cold, ruthless and calculating manner
 Over-controller (Paranoid and obsessive–compulsive) Focuses attention, ruminates and exercises extreme control in attempt to protect self 
from perceived or real threats paranoid types try to locate/uncover hidden threats; obsessive types use order, repetition, or ritual
Healthy adult mode
Serves as an “executive function” in which the healthy adult part nurtures and protects the vulnerable lonely child, sets limits for the angry child 
and battles or moderates the maladaptive coping modes so helping to meet the child’s emotional needs
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risk but involve a sense of self that other animals and even 
primates do not have. While these may be unique to Homo 
sapiens, the most important and central factor in the devel-
opment and resolution of suicidal risk involves the Vulner-
able Child mode; one we share with all other mammals.
All of the EMS (except for Entitlement/Grandiosity and 
Self-Sacrifice) have shown significant correlations with the 
temperament dimension “negative affectivity” and the trait 
“neuroticism” in child, adolescent and adult samples (Muris 
2006; thimm 2010; Rijkeboer and de Boo 2010). As men-
tioned above, consistent and strong correlations have been 
found between various measures of BPD and neuroticism. 
Consistent with this finding, it is observed clinically that 
when BPD patients fill out the Young Schema Question-
naire (Young 2005), a self-report inventory use to assess 
EMS, they almost always score highly on almost all 18 of 
the schemas making up the inventory.
negative affectivity and anxiety proneness (precursors 
to neuroticism in adulthood) are associated with greater 
parental needs of the child (Van den Boom and Hocksma 
1994). A prospective study that focused on the issue of 
how to best parent a needy child and that lends support to 
the plasticity hypothesis in relation to neuroticism and the 
s allele was conducted by Suomi (1997). the study inves-
tigated the developmental outcome of insufficient, normal 
and exceptionally good parenting of infant rhesus macaque 
monkeys with both normal and “neurotic” temperaments. 
One of the findings was that infant monkeys with nor-
mal temperament raised by inadequate parents (i.e. peers) 
developed behavioural and physiological characteristics of 
neurotic infants raised by normal parents. Infant monkeys 
with a neurotic temperament raised by normal mothers 
developed deficits in early exploration, exaggerated star-
tle responses to minor stressors and a less secure attach-
ment and were more likely to remain at the bottom of the 
dominance hierarchy. Interestingly, infant monkeys with 
a neurotic temperament raised by parents with exception-
ally good parenting skills (i.e. being notably loving, nurtur-
ing and patient; qualities that are known to be essential for 
effective St) expressed an even better developmental tra-
jectory than infants with a normal temperament raised by 
normal parents. For example, they explored their environ-
ment more, displayed less behavioural disturbance during 
weaning, had an unusually secure attachment, rose to and 
maintained top positions in the dominance hierarchy and 
became highly nurturing parents themselves. the develop-
mental trajectory of normal infants raised by exceptionally 
good parents was the same as that when raised by normal 
parents so the extra nurturance seemed to make no differ-
ence. Being a prospective study with primates, it allowed 
for control of all relevant variables throughout the period 
of investigation, making conclusions about causality more 
reliable than even the most tightly controlled prospective 
studies possible with humans. We therefore view this 
study as a striking example of the potential advantages of 
a responsive and affirmative stance towards the needs of 
patients with a temperament characterized by neuroticism, 
negative affectivity and increased risk of suicidal behaviour 
such as those diagnosed with BPD.
An outcome study in which St was compared to trans-
ference focused therapy (tFP) in the treatment of BPD 
produced findings consistent with those discussed above 
(Giesen-Bloo et al. 2006). St was found to be twice as 
effective as tFP and led to a significant reduction in all 
BPD manifestations and related psychopathology includ-
ing suicidal risk and behaviour. St also had a significantly 
lower dropout rate. It is worth noting that St was still 
found to be twice as effective even when controlling for 
the lower dropout rate. this strengthens the greater impact 
of St on suicidal behaviour and risk since it retained 
more patients who would otherwise be left at higher risk 
and more quickly and effectively reduced suicidal behav-
iour and other BPD symptomatology in the patients that 
remained in the study. the Schema therapists in the study 
were selected and trained with a focus on being warm and 
highly nurturing in response to the BPD patient’s intense 
affect and needs for soothing. this involved the therapists 
making direct contact with the patient’s Vulnerable Child 
mode and providing emotional nutriments such as sooth-
ing, reassurance, validation, understanding and praise, 
along with empathic limits when needed. the experi-
ences are seen as being internalized and thereby building 
the healthy adult part of the patient. tFP therapists, on the 
other hand, focused on the adult part of their patients, help-
ing them gain a better insight into the nature of their needs 
and feelings and through this, learn how to better tolerate 
painful affect and self-sooth. A key difference between 
these two approaches, and between St and almost all other 
therapies including DBt, is captured in this distinction 
between the internalization of “other-soothing” and train-
ing in “self-soothing”. the former involves the assumption 
that the ability to self-sooth will grow spontaneously out of 
gratifying dependency needs. the latter involves a belief 
that directly gratifying patients’ longings to be soothed 
and nurtured will do the opposite—impede and undermine 
the development of the capacity to self-sooth. notably, the 
nurturing monkey parents were operating on the basis of 
internalization of other-soothing. We do not necessarily 
see this as a difference between good and bad. For children 
with less sensitive temperaments, there appears to be little 
difference between normal and exceptionally loving par-
enting and many young children and patients with either 
temperament can be trained to self-sooth. Moreover, a large 
percentage of the patients treated with tFP derived signifi-
cant benefit. We believe, however, that providing training 
in self-soothing in response to these early core emotional 
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needs could facilitate the development of compulsive self-
reliance and risks promoting detachment from self and oth-
ers as a means of coping with intense affect. this can result 
in individuals with more sensitive natures (e.g. s allele 
carries) not having full access to the nutriments that allow 
them to flourish. St seems to be especially effective in its 
ability to capitalize on the plasticity associated with the s 
allele and more sensitive temperaments, including patients 
with BPD, and in so doing, to more effectively reduce or 
eliminate suicidal risk and behaviour.
the importance of “other-soothing” in relation to BPD 
is seen in the third significant correlation (in the negative 
direction) between this diagnosis and the Agreeableness 
scale of the nEO PI-r (Samual and Widiger 2008; Sauls-
man and Page 2004). this reflects the great difficulty of 
those diagnosed with BPD to trust and get along with oth-
ers. the latter, in combination with the intense emotional 
suffering BPD patients endure, leaves them cut off from the 
soothing and responsiveness they need, thus falling back on 
compulsive self-reliance. the patients in the Giesen-Bloo 
et al. (2006) study attributed a large part of St effective-
ness to the extent the therapist actively reached out to form 
a connection with, and be responsive and soothing to, their 
vulnerable or “child side”. this was also believed to be a 
major factor in the lower dropout rate.
the nEO PI-r neuroticism, Conscientiousness and 
Agreeableness scales were all found to correlate with BPD. 
the combination of correlations on these three dimensions 
is unique to BPD. the strength of the correlation with neu-
roticism is also central. While, for example, APD also cor-
relates significantly in a negative direction with Agreeable-
ness and Conscientiousness, it correlates negatively rather 
than positively with neuroticism. the correlations found 
with BPD overlap well with the mode model that forms a 
central framework for the St approach to this disorder. St 
views BPD as made up of four distinct modes: the Vulner-
able Child, Angry/Impulsive Child, Detached Protector and 
Punitive Parent modes. the Vulnerable Child mode is asso-
ciated with reactions such as fear, anxiety, sadness, lone-
liness and hopelessness and thus has a clear link to neu-
roticism. the Angry/Impulsive Child mode corresponds 
with low Conscientiousness since the latter is associated 
with difficulties with restraint and impulse control. the 
Detached Protector mode is characterized by difficulty 
trusting others and a tendency towards interpersonal vigi-
lance and keeping an emotional distance form oneself and 
others. this pattern is consistent with what is defined as 
low Agreeableness. the Punitive Parent mode (a critical/
punitive aspect of the self) generates feelings such as low 
self-esteem, self-loathing, shame and guilt and is clearly 
linked to neuroticism with a focus on the internal activ-
ity through which these feelings are generated. this over-
lap lends support to the mode model as a comprehensive 
framework with which to organize the key dimensions of a 
BPD patient’s functioning and to its emphasis on the Vul-
nerable Child mode as the core of the treatment process. 
In addition to the “other-soothing” aspect of St (a key ele-
ment of a process called “limited reparenting”), the mode 
model was seen by the patients in the study as being one of 
the most helpful features of the treatment.
the results of this study were replicated by nadort et al. 
(2009) in a second large-scale trial of St in the treatment 
of BPD testing to see if St could be successfully imple-
mented in regular treatment settings. A randomized control 
trial of Group St in comparison with treatment as usual in 
the treatment of BPD found Group St to be significantly 
more effective and to have a significantly lower dropout 
rate (Farrell et al. 2009). the results of these studies were 
as strong as or stronger than the Giesen-Bloo et al. (2006) 
study suggesting that St shows considerable promise as 
an approach to decrease the risk and incidence of suicidal 
behaviour.
Lending support to the hypothesized link between rhesus 
macaques, humans and neuroticism discussed above and 
for the previous discussion on animal models of suicide is 
that fact that animals, and especially primates such as rhe-
sus macaques, exhibit individual differences in behaviour 
that mirror most of the major temperament dimensions in 
childhood and Big Five personality traits in adults (Wein-
stein et al. 2008). Only effortful control (Conscientious-
ness) is not widely evident in other species, although it can 
be observed in chimpanzees.
Conclusions
It has been argued that, from a neurobiological perspective, 
suicidal behaviour is related to functional abnormalities 
in specific brain regions that have been associated with a 
person’s experience of the continuity of self, goal setting, 
decision making and emotion regulation. Biological suicide 
research has largely focused on low serotonin turnover. In 
current neurobiologically informed models, genetic predis-
position and adverse childhood experiences (i.e. biological 
and psychosocial factors) are thought to interact during the 
developmental years, eventually resulting in the manifesta-
tion of neurobiological and clinical factors associated with 
suicidal behaviour. Clinically, these characteristics appear 
to be related to traits such as impulsivity and aggression, 
hopelessness and impaired problem-solving capacities.
Emerging studies on the nature of the genetic poly-
morphisms that underlie these abnormalities suggest that 
a paradigmatic shift is unfolding that sheds a new and 
brighter light on what has been viewed strictly in terms of 
the neurobiology of vulnerability. It appears that many of 
those who have less efficient serotonergic systems suffer 
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the most and who are at the greatest risk of suicide suffer 
greatly in toxic and depriving environments and benefit the 
most from highly nurturing environments. these individu-
als may in fact have an especially strong capacity for deep 
and meaningful relationships, and St seems to be espe-
cially well suited to capitalizing on these strengths, allow-
ing these individuals to move beyond coping and reduced 
suicidal risk to living rich and deeply connected lives.
the developments in the field of neuroscience are now 
leading to a deeper and more precise understanding of how 
and why approaches such as St are especially effective in 
the treatment of suicidal risk. the continuing integration of 
psychotherapeutic models with neurobiological concepts 
has the potential to help build on these early successes and 
to lead to the development of better therapies for suicidal 
individuals. It is conceivable that in the future, neuroimag-
ing studies will help to identify which treatments are effec-
tive in increasing resilience to stressful experiences after 
one or several suicide attempts. neurobiological perspec-
tives of understanding are no contradiction to patient-ori-
ented models of suicide.
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